Evonik

What Evonik does

Evonik Industries AG is a publicly traded German specialty chemicals company (Frankfurt Stock Exchange: EVK) headquartered in Essen, Germany, with North American operations anchored in Parsippany, New Jersey (recently relocated to Piscataway, NJ). Founded in 2007 from the restructuring of RAG's chemical activities, the company is organized into three reporting segments — Specialty Additives (Active Oxygens, Coating Additives, Crosslinkers, Oil Additives), Advanced Technologies (High Performance Polymers, Health Care, Catalysts), and Surface & Interface Technologies (Care Solutions, Interface & Performance) — and serves end markets including automotive, pharmaceuticals & biopharma, healthcare & medical devices, personal care, agriculture, aerospace & defense, additive manufacturing, and electronics & telecommunications.

The company's core technology platform spans high-performance polymers (VESTAKEEP PEEK, VESTAMID polyamide 12, ACRYLITE acrylics), pharmaceutical intermediates (lipid excipients for mRNA therapeutics, EUDRAGIT functional coatings, RESOMER and LACTEL biodegradable/absorbable polymers), specialty silica (precipitated silica for green tires and ultra-high-purity colloidal silica for semiconductors), active oxygens (hydrogen peroxide, peracetic acid, persulfates), and emerging Innovation Factory platforms (DURAION battery recycling, Rheticus and Rhamses X CO2 conversion). Production is anchored at 30+ major North American sites including Tippecanoe Laboratories in Lafayette, Indiana (lipids), Charleston, SC (precipitated silica), Mobile, Alabama, Weston, Michigan (colloidal silica), and Theodore (the largest North American facility).

Evonik's business model is B2B enterprise sales of specialty chemical inputs under quote-based pricing, with revenue generated through a global direct sales force supplemented by channel partners (e.g., exclusive U.S. distribution of cleaning solutions via Sea-Land Chemical Company) and corporate e-commerce storefronts. The company reported FY2024 sales of €15.2 billion globally, with North America at €3.7 billion (24%), and employs approximately 32,000 people worldwide, including 5,000 in North America, operating across 100+ countries. Customer relationships are characterized by long regulatory qualification cycles, particularly in pharmaceutical excipients and medical-grade polymers, which support stickiness once qualified.

Name

Evonik

Legal name

Evonik Industries AG

Website

https://corporate.evonik.us

Company type

Public

Founded year

2007

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Evonik Industries AG is a German publicly traded specialty chemicals company producing high-performance polymers, pharmaceutical lipids, specialty silica, and active oxygens for enterprise customers in automotive, pharmaceuticals, healthcare, electronics, and industrial end markets across 100+ countries.

Ownership category

akta.pro rank

Product category

Specialty Chemicals

NAICS

Resin and Synthetic Rubber Manufacturing (32521), Petrochemical Manufacturing (32511), Adhesive Manufacturing (325520), Surface Active Agent Manufacturing (325613)

SIC

Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821), Industrial Organic Chemicals (2860), Adhesives & Sealants (2891), Plastics Foam Products (3086)

akta.pro primary industry

Specialty Polymers & Resins (Engineered Materials) (IMAEABAK)

akta.pro secondary industries

Personal Care & Cosmetic Ingredients (IMAEABAJ), Encapsulation & Emulsified Delivery Systems (Spray-dried emulsions, Lipid microencapsulation) (AFAJACAL), Adhesives & Sealants Chemicals (IMAEABAA), Medical & Food-Contact Specialty Compounds (IMANABAK)

Keywords

• Specialty chemicals
• High performance polymers
• Pharmaceutical intermediates
• Active oxygens
• Specialty additives

Headquarters

HQ city

Parsippany

HQ country

United States

HQ region

North America

Offices29 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Infrastructure, Marketing or Sales

Revenue model

1. Specialty Chemicals Products and Solutions: Sale of specialty chemicals across multiple segments including healthcare, nutrition, and resource efficiency applications. Revenue generated through direct sales, channel partners, and distributors to enterprise customers.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Evonik manufactures and sells specialty chemicals including high-performance polymers (PEEK, polyamide 12), pharmaceutical lipids for mRNA therapeutics, specialty silica (precipitated and colloidal), and active oxygens (hydrogen peroxide, peracetic acid, persulfates). The company supplies these materials to enterprise customers across automotive, healthcare, pharmaceutical, electronics, and industrial end markets via direct sales and channel distributors.

Product overview

Evonik is a specialty chemicals company organized around three core segments: Specialty Additives (Active Oxygens, Coating Additives, Crosslinkers, Oil Additives), Advanced Technologies (High Performance Polymers, Health Care, Catalysts), and Surface & Interface Technologies (Care Solutions, Interface & Performance). The company offers a broad portfolio of high-performance polymers including VESTAKEEP PEEK for medical and industrial applications, VESTAMID polyamide 12 for gas pipelines and automotive uses, and ACRYLITE acrylic sheet products for lighting and construction. In pharmaceuticals, Evonik supplies lipid intermediates for mRNA therapeutics through its Tippecanoe Laboratories hub, along with biodegradable RESOMER polymers and LACTEL absorbable polymers for medical devices. The Health Care business line provides functional excipients like EUDRAGIT coating polymers, while the Active Oxygens portfolio includes hydrogen peroxide, peracetic acid, and persulfates for industrial and environmental applications. Evonik's Innovation Factory develops emerging technologies including battery recycling (DURAION) and CO2 conversion platforms (Rheticus, Rhamses X). The company operates over 30 major production sites across North America and serves diverse end markets including automotive, pharmaceuticals, healthcare, electronics, and agriculture.

Differentiator

Problem solved

Functional benefit

Brands

• VESTAKEEP: PEEK polymer biomaterial for medical implants and industrial applications
• VESTAMID
• ACRYLITE
• EUDRAGIT
• RESOMER
• Lactel
• VISIOMER
• TEGO
• SEPURAN
• STOKO
• TOMADOL
• TOMAKLEEN
• DEGAROUTE
• Biolys
• CYREX
• Aerosil
• Aeroxide

Products and services

• VESTAKEEP PEEK Polyetheretherketone (PEEK) polymer for medical implants, automotive components, and industrial applications requiring high performance under demanding conditions.
• VESTAMID

Segments8 records

Ideal customer profiles7 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• SINTX TechnologiescoreStrategic or Co-development Partner · 1 January 2024Supply agreement for silicon nitride-PEEK compound specifically designed for AI-assisted 3D-printed patient-specific implants. This partnership combines SINTX's materials expertise with Evonik's polymer technology for advanced medical device applications.
• Sea-Land Chemical CompanycoreChannel Partner/ Reseller/ DistributorExclusive U.S. distribution agreement for cleaning solutions. Sea-Land Chemical Company serves as the exclusive distributor for Evonik's cleaning solution product line in the United States market.

Scale indicators6 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Lanxess: German specialty chemicals company of similar scale focused on specialty additives, high-performance materials, and industrial intermediates. Directly comparable given overlap in specialty additives for automotive, construction, and industrial applications; both companies underwent portfolio rationalization to focus on specialties.
• Arkema: French specialty materials company with overlapping portfolio in specialty adhesives (Bostik), advanced materials, and coating solutions. Highly comparable peer given similar specialty positioning in performance polymers, methacrylates (note: Evonik acquired Arkema's methacrylate specialty esters business in 2010), and high-growth materials for lightweighting and electronics.
• Croda International: British specialty chemicals company focused on personal care, life sciences, and performance technologies. Comparable through overlapping personal care ingredients (surfactants, conditioning agents), pharmaceutical excipients, and biosurfactant technology, with similar high-margin specialty positioning.
• Solvay: Belgian specialty chemicals company with overlapping portfolios in specialty polymers, composite materials, silica, and advanced additives. Highly comparable peer given similar specialty positioning across multiple end markets including automotive, aerospace, and consumer goods.
• DuPont: Specialty chemicals and advanced materials company with closely aligned portfolio in high-performance polymers (including polyamides and engineering plastics), electronics materials, and healthcare-related specialty products. Directly comparable as a specialty-focused peer competing in similar application spaces, particularly in automotive, electronics, and healthcare.
• Shin-Etsu Chemical: Japanese specialty chemicals leader in silicones, specialty polymers (PVC, PEEK-adjacent high-performance materials), and semiconductor materials. Comparable through shared position in high-purity silica for semiconductor applications (similar to Evonik's Weston colloidal silica) and high-performance engineered polymers serving electronics and industrial markets.
• Wacker Chemie: German specialty chemicals company with overlapping portfolio in silicones, polysilicon, specialty polymers, and biotech/pharmaceutical materials. Comparable through shared German mid-cap specialty chemicals positioning, biotech contract manufacturing (similar to Tippecanoe Labs), and engineered materials for electronics and healthcare.

Broad incumbents

• BASF: Germany's largest chemical company and a global broad incumbent with overlapping portfolios in specialty polymers, performance materials, agricultural solutions, and care chemicals. Directly comparable given similar specialty additives, coating additives, and engineering plastics businesses, though BASF operates at significantly larger scale and broader scope.
• DSM (dsm-firmenich): Dutch specialty ingredients company with overlapping exposure to nutrition (animal feed amino acids similar to Evonik's Biolys/methionine), personal care, and pharmaceutical/biomedical materials. Comparable through shared focus on health, nutrition, and specialty ingredients portfolios with similar end-market diversification.
• Dow Chemical: U.S.-headquartered broad incumbent chemicals company with overlapping specialty plastics, performance materials, and industrial intermediates. Comparable through similar B2B specialty materials serving automotive, packaging, and infrastructure end markets, though Dow is significantly larger and more commodity-exposed.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/evonikn_america
• YouTubeyoutube.com/user/EvonikIndustries
• Facebookfacebook.com/Evonik
• LinkedInlinkedin.com/company/evonik
• Instagraminstagram.com/evonikofficial
• TikToktiktok.com/@evonikofficial

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evonik